HbA1c Rapid Quantitative Test

HbA1c is the product of the hemoglobin combining with blood glucose in red blood cells, which can reflect the average blood glucose level over the amid 2-3 months.

MAU Rapid Quantitative Test

MAU(Microalbumin) occurs when the kidney leaks small amounts of albumin into the urine, which is an early marker of kidney damage.

Cys-C Rapid Quantitative Test

Serum Cystatin C(Cys-C) has been proposed as a marker of glomerular filtration rate(GFR). Serum creatinine (creatinine) is widely used to estimate the glomerular filtration rate, but its tubular secretion, dependence on muscle mass, alteration in some inflammatory diseases, and analytical interferences can limit its utility. Thus, Cys-C has been proposed as a novel biomarker of kidney function.

SAA Rapid Quantitative Test (Chemiluminescence Immunoassay)

SAA Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Serum amyloid A (SAA) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.

Lp-PLA2 Rapid Quantitative Test

Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an enzyme that plays a role in the inflammation of blood vessels and is thought to help promote atherosclerosis. Biotime rapid quantitative test kit measures the amount or activity of Lp-PLA2 in the human blood.

ICE-100E Incubation Chamber

The incubation chamber is an auxiliary device for Biotime’s fluorescence immunoassay analyzer. The reaction temperature and time is critical for test results. The incubation chamber provides an optimized environment as well as automatic timers for test reactions to improve the reliability of test results.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

SARS-CoV-2 Neutralizing Antibody Rapid Test

Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

ASO Rapid Quantitative Test (Fluorescence Immunoassay)

The Biotime ASO Rapid Quantitative Test is intended to quantify the concentration of ASO in human serum, plasma and whole blood onBiotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid detection of auxiliary diagnosis of acute rheumatic fever. -Fluorescence immunoassay -Auxiliary diagnosis of acute rheumatic fever For in vitro diagnostic use only. For professional use only.

Specimen Types	WB
Specimen Capacity	5μL
Reaction Time	5 min
Sample Capacity	80μL
Detection Range	4-15%

Fluorescence Immunoassay

Diabetes and Renal Injury Marker

HbA1c Rapid Quantitative Test